Stockreport

Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025

Spyre Therapeutics, Inc.  (SYRE) 
PDF WALTHAM, Mass., Oct. 05, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engi [Read more]